Allianz Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-216,600
| Closed | -$925K | – | 1664 |
|
|
2023
Q2 | $925K | Buy |
+216,600
| New | +$925K | ﹤0.01% | 1175 |
|
|
2021
Q2 | – | Sell |
-170,168
| Closed | -$2.49M | – | 1918 |
|
|
2021
Q1 | $2.49M | Buy |
170,168
+64,453
| +61% | +$942K | ﹤0.01% | 1206 |
|
|
2020
Q4 | $1.84M | Hold |
105,715
| – | – | ﹤0.01% | 1323 |
|
|
2020
Q3 | $1.94M | Sell |
105,715
-14,424
| -12% | -$265K | ﹤0.01% | 1259 |
|
|
2020
Q2 | $2.15M | Buy |
120,139
+100,479
| +511% | +$1.79M | ﹤0.01% | 1245 |
|
|
2020
Q1 | $318K | Sell |
19,660
-9,453
| -32% | -$153K | ﹤0.01% | 1752 |
|
|
2019
Q4 | $525K | Sell |
29,113
-137
| -0.5% | -$2.47K | ﹤0.01% | 1907 |
|
|
2019
Q3 | $592K | Buy |
+29,250
| New | +$592K | ﹤0.01% | 1841 |
|
|
2017
Q2 | – | Sell |
-189,745
| Closed | -$3.98M | – | 2065 |
|
|
2017
Q1 | $3.98M | Buy |
189,745
+27,140
| +17% | +$569K | ﹤0.01% | 1267 |
|
|
2016
Q4 | $4.58M | Buy |
162,605
+20,300
| +14% | +$571K | ﹤0.01% | 1233 |
|
|
2016
Q3 | $3.74M | Buy |
142,305
+96,046
| +208% | +$2.52M | ﹤0.01% | 1291 |
|
|
2016
Q2 | $781K | Buy |
+46,259
| New | +$781K | ﹤0.01% | 1691 |
|